Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07NBA
|
||||
Former ID |
DNCL001564
|
||||
Drug Name |
Veltuzumab
|
||||
Drug Type |
Monoclonal antibody
|
||||
Company |
Takeda
|
||||
CAS Number |
CAS 728917-18-8
|
||||
Target and Pathway | |||||
Target(s) | B-lymphocyte antigen CD20 | Target Info | Modulator | [530047] | |
KEGG Pathway | Hematopoietic cell lineage | ||||
References | |||||
Ref 523540 | ClinicalTrials.gov (NCT01390545) VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis. U.S. National Institutes of Health. | ||||
Ref 543023 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8268). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.